Music and mindfulness: a new way to ease stress in black communities?
NCT ID NCT06513910
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a virtual, community-based program combining music and mindfulness can help People of African Descent manage stress, anxiety, and depression during COVID-19. Researchers will measure brain activity and feelings of social connection in 48 participants as they listen to music together. The goal is to see if culturally relevant, low-cost programs can support mental health in marginalized groups.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- music listening and mindfulness
- What this could lead to
- If successful, this could point toward culturally relevant, low-cost community programs to reduce stress in marginalized groups.
- What could go wrong
- This is a small, early-stage study (48 participants) focused on brain activity and self-reported feelings, not clinical outcomes. Results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BLOOM
RECRUITINGNew Haven, Connecticut, 06515, United States
-
Musical Intervention Studios
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?